Table of Content
"1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
FIGURE 1 GASTROINTESTINAL STENT MARKET 31
1.3.2 YEARS CONSIDERED FOR STUDY 31
1.4 CURRENCY 32
TABLE 1 STANDARD CURRENCY CONVERSION RATES 32
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH APPROACH 35
FIGURE 2 GASTROINTESTINAL STENT MARKET: RESEARCH METHODOLOGY STEPS 35
FIGURE 3 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
FIGURE 4 PRIMARY SOURCES 39
2.1.2.1 Key data from primary sources 40
2.1.2.2 Key industry insights 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS (GASTROINTESTINAL STENT MARKET) 41
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.2 MARKET SIZE ESTIMATION 41
FIGURE 7 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BOSTON SCIENTIFIC CORPORATION 42
FIGURE 9 SUPPLY SIDE MARKET SIZE ESTIMATION: GASTROINTESTINAL STENT MARKET (2020) 43
FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 44
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR GASTROINTESTINAL STENT MARKET (2021–2026) 44
FIGURE 12 TOP-DOWN APPROACH 45
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 46
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 46
2.4 ASSUMPTIONS FOR THE STUDY 47
2.5 LIMITATIONS 47
2.5.1 METHODOLOGY-RELATED LIMITATIONS 47
2.6 RISK ASSESSMENT 48
2.7 ASSESSMENT OF IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET 48
3 EXECUTIVE SUMMARY 49
FIGURE 14 GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 49
FIGURE 15 GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2021 VS. 2026 (USD MILLION) 50
FIGURE 16 GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 51
FIGURE 17 GASTROINTESTINAL STENT MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 51
FIGURE 18 GEOGRAPHIC SNAPSHOT OF GASTROINTESTINAL STENT MARKET 52
4 PREMIUM INSIGHTS 53
4.1 GASTROINTESTINAL STENT MARKET OVERVIEW 53
FIGURE 19 RISE IN INCIDENCE OF GASTROINTESTINAL CANCERS, IBD, AND OTHER DIGESTIVE DISEASES DRIVE GASTROINTESTINAL STENT MARKET GROWTH 53
4.2 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT AND COUNTRY 54
FIGURE 20 BILIARY STENT HELD LARGEST SHARE OF NORTH AMERICAN MARKET
IN 2020 54
4.3 GASTROINTESTINAL STENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 21 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 55
4.4 GASTROINTESTINAL STENT MARKET: REGIONAL MIX 55
FIGURE 22 NORTH AMERICA TO BE LARGEST MARKET FOR GASTROINTESTINAL
STENT THROUGHOUT FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 23 GASTROINTESTINAL STENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
5.2.1 DRIVERS 57
5.2.1.1 Rise in the incidence of gastrointestinal cancers, IBD, and
other digestive diseases 57
TABLE 2 GLOBAL INCIDENCE OF COLORECTAL CANCER, 2020 57
TABLE 3 GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2020 57
5.2.1.2 Increasing healthcare expenditure on gastrointestinal procedures 58
FIGURE 24 EUROPE: COSTS OF GASTROINTESTINAL CANCERS (USD BILLION), 2018 58
5.2.1.3 Ongoing technological advancements in business space 59
5.2.1.4 Increasing preference for minimally invasive surgeries 59
5.2.2 RESTRAINTS 60
5.2.2.1 Major complications associated with GI stent implementation 60
TABLE 4 FREQUENCY OF MOST COMMON STENT-RELATED COMPLICATIONS IN VARIOUS ANATOMIC SITES 60
5.2.2.2 High cost of the procedure and limited reimbursement in
developing countries 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Development of biodegradable and drug eluting stents 61
5.2.3.2 Growing healthcare sector in emerging economies 61
5.2.4 CHALLENGES 62
5.2.4.1 Stringent regulatory environment 62
6 INDUSTRY INSIGHT S 63
6.1 TECHNOLOGY ANALYSIS 63
6.1.1 RECENT ADVANCES IN GASTROINTESTINAL STENTING TO OFFER IMPROVED STENT PATENCY AND REDUCED STENT-INDUCED COMPLICATIONS, RESULTING IN IMPROVED QUALITY OF LIFE 63
6.2 PRICING ANALYSIS 64
TABLE 5 PRICES FOR GI STENTS (USD) 64
6.3 VALUE CHAIN ANALYSIS 64
FIGURE 25 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE 65
6.4 ECOSYSTEM MAPPING 65
FIGURE 26 GASTROINTESTINAL STENT MARKET: ECOSYSTEM ANALYSIS 66
6.5 SUPPLY CHAIN ANALYSIS 66
FIGURE 27 GASTROINTESTINAL STENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN 67
6.6 PORTER’S FIVE FORCES ANALYSIS 68
TABLE 6 GASTROINTESTINAL STENT MARKET: PORTER’S FIVE FORCES ANALYSIS 68
6.6.1 THREAT OF NEW ENTRANTS 68
6.6.1.1 High capital requirement 68
6.6.1.2 High preference for products from well-established brands 69
6.6.2 THREAT OF SUBSTITUTES 69
6.6.2.1 Substitute therapies for gastrointestinal stents 69
6.6.3 BARGAINING POWER OF SUPPLIERS 69
6.6.3.1 Presence of few raw material suppliers 69
6.6.3.2 Supplier switching cost 69
6.6.4 BARGAINING POWER OF BUYERS 69
6.6.4.1 Few companies offer premium products at global level 69
6.6.5 INTENSITY OF COMPETITIVE RIVALRY 70
6.6.5.1 Increasing demand for high-quality and innovative products 70
6.6.5.2 Lucrative growth potential in emerging markets 70
6.7 REGULATORY ANALYSIS 70
TABLE 7 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
THE GASTROINTESTINAL STENT MARKET 70
6.7.1 NORTH AMERICA 71
6.7.1.1 US 71
TABLE 8 US FDA: CLASSIFICATION OF MEDICAL DEVICES 71
6.7.1.2 Canada 71
6.7.2 EUROPE 72
6.7.3 ASIA PACIFIC 72
6.7.3.1 India 72
6.7.3.2 China 72
TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION 73
6.7.3.3 Japan 73
TABLE 10 PMDA: CLASSIFICATION OF MEDICAL DEVICES 73
6.8 PATENT ANALYSIS 74
6.8.1 PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS 74
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN GASTROINTESTINAL STENT MARKET, 2015–2021 74
6.8.2 TOP APPLICANTS (COMPANIES) OF GASTROINTESTINAL STENTS PATENTS 75
FIGURE 29 TOP COMPANIES THAT APPLIED FOR GASTROINTESTINAL STENTS PATENTS, 2018 AND 2021 75
6.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS
IN GASTROINTESTINAL STENT MARKET 75
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR GASTROINTESTINAL STENT PATENTS, 2015–2021 75
6.9 YC–YCC TRENDS/DISRUPTION IMPACTING CUSTOMER BUSINESS 76
FIGURE 31 YC–YCC SHIFT IN GASTROINTESTINAL STENT MARKET 76
6.10 IMPACT OF COVID-19 ON GASTROINTESTINAL STENT MARKET 77
TABLE 11 IMPACT OF COVID-19 ON SALES OF KEY MARKET PLAYERS 77
7 GASTROINTESTINAL STENT MARKET, BY PRODUCT 78
7.1 INTRODUCTION 79
FIGURE 32 BILIARY SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET
BY 2026 79
TABLE 12 GLOBAL GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 79
TABLE 13 GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
7.2 BILIARY STENTS 80
7.2.1 INCREASING PREVALENCE OF BILE DUCT CANCER AND CHRONIC
LIVER DISEASE TO DRIVE THE GROWTH OF THIS SEGMENT 80
TABLE 14 BILIARY STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 81
TABLE 15 BILIARY STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
7.3 COLONIC STENTS 82
7.3.1 RISING DEMAND FOR COLONIC STENTS DUE TO HIGH INCIDENCE OF COLORECTAL CANCER TO DRIVE SEGMENT GROWTH 82
TABLE 16 COLONIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 82
TABLE 17 COLONIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 83
7.4 DUODENAL STENTS 83
7.4.1 INCREASING PREVALENCE OF INTESTINAL MALIGNANCY TO ADOPT DUODENAL STENTS 83
TABLE 18 DUODENAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 84
TABLE 19 DUODENAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
7.5 PANCREATIC STENTS 85
7.5.1 RISING NUMBER OF ERCP AND PTC PROCEDURES TO DRIVE
SEGMENT GROWTH 85
TABLE 20 PANCREATIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 85
TABLE 21 PANCREATIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
7.6 ESOPHAGEAL STENTS 86
7.6.1 INCREASING INCIDENCE OF ESOPHAGEAL CANCER TO DRIVE ESOPHAGEAL STENTS MARKET 86
TABLE 22 ESOPHAGEAL STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 87
TABLE 23 ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
8 GASTROINTESTINAL STENT MARKET, BY MATERIAL 88
8.1 INTRODUCTION 89
FIGURE 33 SELF-EXPANDING METAL STENTS SEGMENT TO DOMINATE GASTROINTESTINAL STENT MARKET BY 2026 89
TABLE 24 GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 89
8.2 SELF-EXPANDING METAL STENTS 90
8.2.1 INCREASING ADOPTION OF SELF-EXPANDING METAL STENTS IN HOSPITAL SETTINGS TO DRIVE THE SEGMENT 90
TABLE 25 SELF-EXPANDING METAL STENTS: KEY PRODUCTS OFFERED
BY THE PROMINENT PLAYERS 90
TABLE 26 SELF-EXPANDING METAL STENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 91
TABLE 27 GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 91
8.2.2 NITINOL STENTS 92
8.2.2.1 Ease of deployment for nitinol stents to drive segment growth 92
TABLE 28 NITINOL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS 92
TABLE 29 NITINOL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 93
8.2.3 STAINLESS STEEL STENTS 93
8.2.3.1 Excellent mechanical properties and medical efficiency of stainless-steel stents to support segment growth 93
TABLE 30 STAINLESS STEEL STENTS: KEY PRODUCTS OFFERED BY THE
PROMINENT PLAYERS 94
TABLE 31 STAINLESS STEEL STENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 94
8.2.4 OTHER METAL STENTS 95
TABLE 32 OTHER METAL STENTS: KEY PRODUCTS OFFERED BY THE PROMINENT PLAYERS 95
TABLE 33 OTHER METAL STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 95
8.3 PLASTIC STENTS 96
8.3.1 FAVORABLE REIMBURSEMENT POLICIES FOR PLASTIC STENTS AND INCREASED DEMAND FOR SHORT-TERM USE OF STENTS TO DRIVE
SEGMENT GROWTH 96
TABLE 34 PLASTIC STENTS: KEY PRODUCTS OFFERED BY PROMINENT PLAYERS 96
TABLE 35 PLASTIC STENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
9 GASTROINTESTINAL STENT MARKET, BY APPLICATION 98
9.1 INTRODUCTION 99
FIGURE 34 BILIARY DISEASES TO DOMINATE GASTROINTESTINAL STENT MARKET,
BY APPLICATION, IN 2026 99
TABLE 36 GASTROINTESTINAL STENT MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION) 99
9.2 BILIARY DISEASES 100
9.2.1 INCREASED AGING POPULATION AND PREVALENCE OF GALLSTONES
TO DRIVE GROWTH 100
TABLE 37 BILIARY DISEASES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 100
9.3 GASTROINTESTINAL CANCER 101
9.3.1 GASTROINTESTINAL CANCER IS THE LARGEST APPLICATION SEGMENT
FOR GASTROINTESTINAL STENT 101
TABLE 38 GASTROINTESTINAL CANCER STENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 101
TABLE 39 GASTROINTESTINAL CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 102
9.3.2 COLORECTAL CANCER 103
9.3.2.1 Rise of colorectal cancer cases to drive segment growth 103
TABLE 40 COLORECTAL CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
9.3.3 STOMACH CANCER 104
9.3.3.1 High incidence rate of stomach cancer to drive market share for stomach cancer 104
TABLE 41 STOMACH CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
9.3.4 PANCREATIC CANCER 105
9.3.4.1 Increased prevalence of pancreatic cancer and adoption of stents in endoscopic procedures to drive segment growth 105
TABLE 42 PANCREATIC CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 105
9.3.5 ESOPHAGEAL CANCER 106
9.3.5.1 Increasing number of esophageal cancer to increase adoption
of esophageal stents 106
TABLE 43 ESOPHAGEAL CANCER STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 106
9.4 IRRITABLE BOWEL SYNDROME 107
9.4.1 INCREASED PREVALENCE OF IRRITABLE BOWEL SYNDROME TO DRIVE DEMAND FOR GI STENTS 107
TABLE 44 IRRITABLE BOWEL SYNDROME STENT MARKET, BY COUNTRY/REGION, 2019–2026 (USD MILLION) 107
10 GASTROINTESTINAL STENT MARKET, BY END USER 108
10.1 INTRODUCTION 109
FIGURE 35 HOSPITALS & CLINICS SEGMENT TO DOMINATE GASTROINTESTINAL
STENT MARKET BY 2026 109
TABLE 45 GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 109
10.2 HOSPITALS & CLINICS 110
10.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL STENTS IN HOSPITALS & CLINICS 110
TABLE 46 REIMBURSEMENT IN HOSPITAL OUTPATIENTS FOR ERCP STENTING PROCEDURES (USD) 111
TABLE 47 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
10.3 AMBULATORY SURGICAL CENTERS 112
10.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE AMBULATORY SURGICAL CENTERS 112
TABLE 48 US: NUMBER OF ASCS, (2013–2018) 112
TABLE 49 REIMBURSEMENT IN ASC FOR ERCP STENTING PROCEDURES (USD) 113
TABLE 50 AMBULATORY SURGICAL CENTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 113
11 GASTROINTESTINAL STENT MARKET, BY REGION 114
11.1 INTRODUCTION 115
FIGURE 36 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL SEGMENT DURING FORECAST PERIOD 115
TABLE 51 GASTROINTESTINAL STENT MARKET, BY REGION, 2019–2026 (USD MILLION) 116
11.2 NORTH AMERICA 116
TABLE 52 NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND 5 YEAR PREVALENCE ( 2020) 116
FIGURE 37 NORTH AMERICA: GASTROINTESTINAL STENT MARKET SNAPSHOT 117
TABLE 53 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
TABLE 54 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 118
TABLE 55 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 118
TABLE 56 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 118
TABLE 57 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 119
TABLE 58 NORTH AMERICA: GASTROINTESTINAL CANCER STENTS MARKET,
BY GASTROINTESTINAL CANCERS, 2019–2026 (USD MILLION) 119
TABLE 59 NORTH AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 119
11.2.1 US 120
11.2.1.1 US to dominate North America gastrointestinal stent market
during forecast period 120
TABLE 60 US: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER
BY GASTROINTESTINAL CANCER (2020) 120
TABLE 61 US: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 121
TABLE 62 US: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 121
TABLE 63 US: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 121
TABLE 64 US: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 122
TABLE 65 US: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 122
TABLE 66 US: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 122
11.2.2 CANADA 123
11.2.2.1 Growing geriatric population and increased incidence of gastrointestinal disorders to drive gastrointestinal stents demand 123
TABLE 67 CANADA: ESTIMATED CASES OF DIGESTIVE SYSTEM CANCER,
BY GASTROINTESTINAL CANCER (2020) 123
TABLE 68 CANADA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 123
TABLE 69 CANADA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 124
TABLE 70 CANADA: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 124
TABLE 71 CANADA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 124
TABLE 72 CANADA: GASTROINTESTINAL CANCER STENTS MARKET,
BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 125
TABLE 73 CANADA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 125
11.3 EUROPE 125
TABLE 74 EUROPE: GASTROINTESTINAL CANCER INCIDENCE, BY GASTROINTESTINAL CANCER (2020) 125
FIGURE 38 EUROPE: GASTROINTESTINAL STENT MARKET SNAPSHOT 126
TABLE 75 EUROPE: GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 127
TABLE 76 EUROPE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 127
TABLE 77 EUROPE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 127
TABLE 78 EUROPE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 128
TABLE 79 EUROPE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 128
TABLE 80 EUROPE: GASTROINTESTINAL CANCER STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 128
TABLE 81 EUROPE: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 129
11.3.1 GERMANY 129
11.3.1.1 Germany dominated the European gastrointestinal stent
market in 2020 129
TABLE 82 GERMANY: GI CANCER INCIDENCE, IN 2020 129
TABLE 83 GERMANY: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 130
TABLE 84 GERMANY: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 130
TABLE 85 GERMANY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 130
TABLE 86 GERMANY: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
TABLE 87 GERMANY: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 131
TABLE 88 GERMANY: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 131
11.3.2 FRANCE 132
11.3.2.1 Favorable statutory health insurance system to boost gastrointestinal stents adoption 132
TABLE 89 FRANCE: GI CANCER INCIDENCE, (2020) 132
TABLE 90 FRANCE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 132
TABLE 91 FRANCE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 133
TABLE 92 FRANCE: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 133
TABLE 93 FRANCE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 133
TABLE 94 FRANCE: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 134
TABLE 95 FRANCE: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 134
11.3.3 UK 134
11.3.3.1 Increased incidence of gastrointestinal cancers and minimally invasive surgeries to increase gastrointestinal stents adoption 134
TABLE 96 UK: GASTROINTESTINAL CANCER INCIDENCE (2020) 135
TABLE 97 UK: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 135
TABLE 98 UK: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 136
TABLE 99 UK: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL,
2019–2026 (USD MILLION) 136
TABLE 100 UK: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 136
TABLE 101 UK: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 137
TABLE 102 UK: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 137
11.3.4 ITALY 137
11.3.4.1 Aging population and initiatives to build awareness about digestive health to increase gastrointestinal stent adoption 137
TABLE 103 ITALY: GASTROINTESTINAL CANCER INCIDENCE (2020) 138
TABLE 104 ITALY: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 138
TABLE 105 ITALY: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 139
TABLE 106 ITALY: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 139
TABLE 107 ITALY: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 108 ITALY: GASTROINTESTINAL CANCER STENT MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 140
TABLE 109 ITALY: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 140
11.3.5 SPAIN 140
11.3.5.1 Increased prevalence of gastrointestinal diseases to raise demand for gastrointestinal stent 140
TABLE 110 SPAIN: GASTROINTESTINAL CANCER INCIDENCE (2020) 140
TABLE 111 SPAIN: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 141
TABLE 112 SPAIN: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 141
TABLE 113 SPAIN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 142
TABLE 114 SPAIN: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
TABLE 115 SPAIN: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 142
TABLE 116 SPAIN: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 143
11.3.6 REST OF EUROPE 143
TABLE 117 ROE: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 144
TABLE 118 ROE: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 144
TABLE 119 ROE: GASTROINTESTINAL SELF-EXPANDING METAL STENTS MARKET,
BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 144
TABLE 120 ROE: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 145
TABLE 121 ROE: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 145
TABLE 122 ROE: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 145
11.4 ASIA PACIFIC 146
TABLE 123 ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE (2020) 146
FIGURE 39 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET SNAPSHOT 147
TABLE 124 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 147
TABLE 125 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 148
TABLE 126 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 148
TABLE 127 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 148
TABLE 128 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 149
TABLE 129 ASIA PACIFIC: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 149
TABLE 130 ASIA PACIFIC: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 149
11.4.1 CHINA 150
11.4.1.1 Increasing healthcare expenditure and government initiatives to modernize healthcare system and support market growth 150
TABLE 131 CHINA: GASTROINTESTINAL CANCER INCIDENCE, (2020) 150
TABLE 132 CHINA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 151
TABLE 133 CHINA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 151
TABLE 134 CHINA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 151
TABLE 135 CHINA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 152
TABLE 136 CHINA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 152
TABLE 137 CHINA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 152
11.4.2 JAPAN 153
11.4.2.1 Strong healthcare system and increased geriatric population
to drive market growth 153
TABLE 138 JAPAN: GASTROINTESTINAL CANCER INCIDENCE (2020) 153
TABLE 139 JAPAN: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 140 JAPAN: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 154
TABLE 141 JAPAN: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 154
TABLE 142 JAPAN: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 155
TABLE 143 JAPAN: GASTROINTESTINAL CANCER STENTS MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 155
TABLE 144 JAPAN: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 155
11.4.3 INDIA 156
11.4.3.1 Increasing prevalence of gastrointestinal disorders and presence of global and local market players to drive market growth 156
TABLE 145 INDIA: GASTROINTESTINAL CANCER INCIDENCE (2020) 156
TABLE 146 INDIA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 147 INDIA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 157
TABLE 148 INDIA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 157
TABLE 149 INDIA: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 150 INDIA: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 158
TABLE 151 INDIA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 158
11.4.4 REST OF ASIA PACIFIC 158
TABLE 152 ROAPAC: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 159
TABLE 153 ROAPAC: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 159
TABLE 154 ROAPAC: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 159
TABLE 155 ROAPAC: GASTROINTESTINAL STENT MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 160
TABLE 156 ROAPAC: GASTROINTESTINAL STENT MARKET, BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 160
TABLE 157 ROAPAC: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 160
11.5 LATIN AMERICA 161
11.5.1 INCREASING DISPOSABLE INCOME AND BURDEN OF GASTRIC
CANCER TO DRIVE MARKET GROWTH 161
TABLE 158 LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, 2020 161
TABLE 159 BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, 2020 161
TABLE 160 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 162
TABLE 161 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL,
2019–2026 (USD MILLION) 162
TABLE 162 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 162
TABLE 163 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 163
TABLE 164 LATIN AMERICA: GASTROINTESTINAL CANCER STENTS MARKET, BT GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 163
TABLE 165 LATIN AMERICA: GASTROINTESTINAL STENT MARKET, BY END USER,
2019–2026 (USD MILLION) 163
11.6 MIDDLE EAST & AFRICA 164
11.6.1 MIDDLE EAST & AFRICA IS THE SMALLEST MARKET FOR GASTROINTESTINAL STENT PRODUCTS 164
TABLE 166 MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020) 164
TABLE 167 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 164
TABLE 168 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY MATERIAL, 2019–2026 (USD MILLION) 165
TABLE 169 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET, BY SELF-EXPANDING METAL, 2019–2026 (USD MILLION) 165
TABLE 170 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 165
TABLE 171 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,
BY GASTROINTESTINAL CANCER, 2019–2026 (USD MILLION) 166
TABLE 172 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENT MARKET,
BY END USER, 2019–2026 (USD MILLION) 166
12 COMPETITIVE LANDSCAPE 167
12.1 OVERVIEW 167
12.2 KEY PLAYER STRATEGIES 167
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 168
12.4 KEY PLAYERS RANKING (2020) 168
FIGURE 41 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 168
12.5 COMPETITIVE BENCHMARKING 170
12.5.1 COMPANY FOOTPRINT FOR KEY PLAYERS 170
12.5.2 PRODUCT AND REGIONAL FOOTPRINT OF COMPANIES
IN GASTROINTESTINAL STENT MARKET 171
TABLE 173 PRODUCT TYPE FOOTPRINT OF COMPANIES (20 MARKET PLAYERS) 172
TABLE 174 MATERIAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS) 173
TABLE 175 REGIONAL FOOTPRINT OF COMPANIES (20 MARKET PLAYERS) 174
12.6 COMPETITIVE LEADERSHIP MAPPING 175
12.6.1 STARS 175
12.6.2 EMERGING LEADERS 175
12.6.3 PERVASIVE PLAYERS 175
12.6.4 PARTICIPANTS 176
FIGURE 42 GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP
MAPPING (2020) 176
12.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 177
12.7.1 PROGRESSIVE COMPANIES 177
12.7.2 DYNAMIC COMPANIES 177
12.7.3 STARTING BLOCKS 177
12.7.4 RESPONSIVE COMPANIES 177
FIGURE 43 GASTROINTESTINAL STENT MARKET: COMPETITIVE LEADERSHIP
MAPPING FOR START-UPS (2020) 178
12.8 COMPETITIVE SCENARIO 178
12.8.1 PRODUCT LAUNCHES & APPROVALS 178
TABLE 176 GASTROINTESTINAL STENT MARKET: KEY PRODUCT LAUNCHES
& APPROVALS, 2018–2021 178
12.8.2 DEALS 179
TABLE 177 GASTROINTESTINAL STENT MARKET: KEY DEALS, 2018–2021 179
13 COMPANY PROFILES 180
13.1 KEY PLAYERS 180
(Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats)*
13.1.1 BOSTON SCIENTIFIC CORPORATION 180
TABLE 178 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 180
FIGURE 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 181
13.1.2 COOK GROUP 183
TABLE 179 COOK GROUP: BUSINESS OVERVIEW 183
13.1.3 TAEWOONG MEDICAL 186
TABLE 180 TAEWOONG MEDICAL: BUSINESS OVERVIEW 186
13.1.4 MICRO-TECH (NANJING) CO., LTD. 188
TABLE 181 MICRO-TECH (NANJING) CO., LTD.: BUSINESS OVERVIEW 188
13.1.5 OLYMPUS CORPORATION 189
TABLE 182 OLYMPUS CORPORATION: BUSINESS OVERVIEW 189
FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020) 190
13.2 OTHER PLAYERS 192
13.2.1 MERIT MEDICAL SYSTEMS 192
TABLE 183 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 192
FIGURE 46 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 193
13.2.2 BECTON, DICKINSON AND COMPANY 195
TABLE 184 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 195
FIGURE 47 BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT (2020) 196
13.2.3 MEDTRONIC 197
TABLE 185 MEDTRONIC: BUSINESS OVERVIEW 197
FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2020) 198
13.2.4 CANTEL MEDICAL 199
TABLE 186 CANTEL MEDICAL: BUSINESS OVERVIEW 199
FIGURE 49 CANTEL MEDICAL: COMPANY SNAPSHOT (2020) 200
13.2.5 CONMED CORPORATION 202
TABLE 187 CONMED CORPORATION: BUSINESS OVERVIEW 202
FIGURE 50 CONMED CORPORATION: COMPANY SNAPSHOT (2020) 203
13.2.6 ELLA-CS, S.R.O. 204
TABLE 188 ELLA-CS, S.R.O.: BUSINESS OVERVIEW 204
13.2.7 ENDO-FLEX GMBH 206
TABLE 189 ENDO-FLEX GMBH: BUSINESS OVERVIEW 206
13.2.8 MI-TECH 207
TABLE 190 MI-TECH : BUSINESS OVERVIEW 207
13.2.9 HOBBS MEDICAL INC. 209
TABLE 191 HOBBS MEDICAL INC.: BUSINESS OVERVIEW 209
13.2.10 QUALIMED 210
TABLE 192 QUALIMED: BUSINESS OVERVIEW 210
13.2.11 UK MEDICAL 211
TABLE 193 UK MEDICAL: BUSINESS OVERVIEW 211
13.2.12 CITEC 212
TABLE 194 CITEC: BUSINESS OVERVIEW 212
13.2.13 MEDORAH MEDITEK PVT. LTD. 213
TABLE 195 MEDORAH MEDITEK PVT. LTD.: BUSINESS OVERVIEW 213
13.2.14 BCM CORPORATION 214
TABLE 196 BCM CORPORATION: BUSINESS OVERVIEW 214
13.2.15 LEUFEN MEDICAL GMBH 215
TABLE 197 LEUFEN MEDICAL GMBH: BUSINESS OVERVIEW 215
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
14 APPENDIX 216
14.1 DISCUSSION GUIDE 216
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220
14.3 AVAILABLE CUSTOMIZATIONS 222
14.4 RELATED REPORTS 222
14.5 AUTHOR DETAILS 223"